Quotables
"Flight by machines heavier than air is unpractical and insignificant, if not utterly impossible."
Simon Newcomb, astronomer ; Said in 1902, less than two years before the first flight at Kitty Hawk
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6006745 | Device for delivering an aerosol A device for delivering an aerosol comprises a casing member, a valve stem, and a sealing member, wherein the sealing member comprises a thermoplastic elastomer comprising of a copolymer of about 80-95 mole % ethylene and about 5-20 mole % of at least one... | 12/28/1999 |
| 5776434 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 07/07/1998 |
| 5766573 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 06/16/1998 |
| 5736553 | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo4,5-C!quinolin-4-amine Pharmaceutical formulations and adhesive-coated sheet materials for the topical and/or transdermal delivery of 1-isobutyl-1H-imidazo4,5-c!-quinolin-4-amine, including creams, ointments and pressure-sensitive adhesive compositions. Pharmacological method... | 04/07/1998 |
| 5725841 | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid A medicinal aerosol formulation containing a particulate drug and a dispersing aid derived from a hydroxyacid, a mercapto acid, or an amino acid.... | 03/10/1998 |
| 5702720 | Transdermal device for the delivery of flurbiprofen A transdermal drag delivery device involving an acrylate or methacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer, and a therapeutically effective amount of flurbiprofen.... | 12/30/1997 |
| 5698217 | Transdermal drug delivery device containing a desiccant A transdermal drug delivery device involving a carrier containing a dissolved drug. The device also involves a desiccant package that is inert to the carrier, permeable to water vapor, and defines a desiccant compartment containing a desiccant. The device... | 12/16/1997 |
| 5695743 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 12/09/1997 |
| 5693811 | Process for preparing tetrahdroimidazoquinolinamines A process for preparing 6, 7, 8, 9-tetrahydro-1H-imidazo4,5-c!quinolin-4-amines is disclosed. The process involves the reduction of a 1H-imidazo4,5-c!quinolin-4-amine or of a 6H-imidazo4,5-c!tetrazolo1,5-a!quinoline.... | 12/02/1997 |
| 5688520 | Transmucosal delivery of melatonin for prevention of migraine A method of reducing the frequency of and/or preventing migraine, involving the step of administering melatonin, preferably to and across a mucosal surface, in an amount and for a time sufficient to increase the period of time between episodes of migraine... | 11/18/1997 |
| 5688523 | Method of making a pressure sensitive skin adhesive sheet material A method of making a pressure sensitive skin adhesive sheet material whereby a coating medium involving a liquid and a polymer is applied to a base layer of a polymer, and the liquid is allowed to diffuse into the base layer.... | 11/18/1997 |
| 5681545 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 10/28/1997 |
| 5674473 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 10/07/1997 |
| 5669376 | Aerosol actuator having a linearly arranged canister receiving cavity, valve stem receptacle, orifice, and deagglomeration chamber An actuator for use in inhalation therapy comprising a nozzle .block having an orifice and at least one bleed hole, a deagglomeration chamber, and an exit chamber, together configured as a means for increasing the respirable fraction of an aerosol formula... | 09/23/1997 |
| 5655523 | Dry powder inhalation device having deagglomeration/aerosolization structure responsive to patient inhalation An inhalation device for dry powder containing a chamber capable of receiving a dose of powdered medicament. The chamber is in communication with a patient port in the form of a mouthpiece or nasal adapter. The inhalation device also contains a deagglomer... | 08/12/1997 |
| 5653961 | Butixocort aerosol formulations in hydrofluorocarbon propellant Pharmaceutical solution aerosol formulations of butixocort propionate as the sole active drug agent and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, and a mixture thereof.... | 08/05/1997 |
| 5648516 | Fused cycloalkylimidazopyridines 6,7-propylene-, butylene-, or pentylene-bridged imidazopyridin-4-amines that induce interferon () biosynthesis in human cells, their pharmaceutical compositions containing such compounds and methods of inducing interferon () biosynthesis and... | 07/15/1997 |
| 5644063 | Imidazo[4,5-c]pyridin-4-amine intermediates Imidazo[4,5-c]pyridin-4-amines that induce interferon () biosynthesis in human cells. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon () biosynthesis involving the use of such compo... | 07/01/1997 |
| 5639469 | Transmucosal delivery system A device for delivering a heparinic anticoagulant across a mucosal surface in order to achieve or maintain a therapeutically effective blood level of the heparinic anticoagulant. The device involves a matrix containing a therapeutically effective amount o... | 06/17/1997 |
| 5627281 | Intermediate compounds of fused cycloalkylimidazopyridines 6,7-propylene-, butylene-, or pentylene-bridged imidazopyridin-4-amines and their intermediate compounds are described. Also disclosed are pharmaceutical compositions containing such compounds and methods of inducing interferon () biosynthesis and ... | 05/06/1997 |
| 5614210 | Transdermal device for the delivery of alfuzosin A transdermal drug delivery device involving an acrylate or methacrylate based adhesive copolymer, a skin penetration enhancer, and a therapeutically effective amount of alfuzosin.... | 03/25/1997 |
| 5612377 | Method of inhibiting leukotriene biosynthesis A method of inhibiting leukotriene biosynthesis, involving administering a compound of the formula: ##STR1## wherein M, R, R', R", and n are as defined herein. Also, a pharmaceutical composition involving such a compound and the use of such compounds... | 03/18/1997 |
| 5605674 | Medicinal aerosol formulations A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.... | 02/25/1997 |
| 5605899 | 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines 1-substituted, 2-substituted 1H-imidazo[4,5-c]-quinolin-4-amines are disclosed. These compounds function as antiviral agents, they induce biosynthesis of interferon, and they inhibit tumor formation in animal models. This invention also provides intermedi... | 02/25/1997 |
| 5602256 | Process for 1H-imidazo[4,5-C]quinolines A process for the preparation of 1-substituted,4-substituted-1H-imidazo-[4,5-c]quinolines, intermediates in the preparation of such compounds, and processes for the preparation of such intermediates.... | 02/11/1997 |
| 5585111 | Transdermal delivery device A transdermal drug delivery device involving a backing bearing at least one adhesive layer of an acrylate copolymer and a therapeutically effective amount of (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole. The device optionally further involves (i) a s... | 12/17/1996 |
| 5578727 | Process for 1H-imidazo[4,5-c]quinolines A process for the preparation of 1-substituted,4-substituted-1H-imidazo-[4,5-c]quinolines, intermediates in the preparation of such compounds, and processes for the preparation of such intermediates.... | 11/26/1996 |
| 5569450 | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid A medicinal aerosol formulation containing a particulate drug and a dispersing aid derived from a hydroxyacid, a mercapto acid, or an amino acid.... | 10/29/1996 |
| 5533498 | Aerosol actuator having a linearly arranged canister receiving cavity, valve stem receptacle, orifice, and deagglomeration chamber An actuator for use in inhalation therapy comprising a nozzle block having an orifice and at least one bleed hole, a deagglomeration chamber, and an exit chamber, together configured as a means for increasing the respirable fraction of an aerosol formulat... | 07/09/1996 |
| 5527824 | Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis Substituted Di-T-Butylphenols useful for inhibiting the synthesis of leukotrienes are disclosed.... | 06/18/1996 |
| 5525612 | 1-substituted 1H-imidazo-[4,5-c]quinolin-4-amines 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines, active as immunomodulators and antiviral agents. Also, intermediates in the preparation of such compounds, pharmaceutical compositions, and pharmacological methods of use.... | 06/11/1996 |
